Ligand Pharmaceuticals
LGND
#4212
Rank
NZ$3.55 B
Marketcap
$184.86
Share price
-2.29%
Change (1 day)
56.63%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.53

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.75. In 2022 the company made an earnings per share (EPS) of -$3.47 a decrease over its 2021 EPS that were of $6.06.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.53-173.14%
2022-$3.47-157.23%
2021$6.06-2571.43%
2020-$0.25-100.46%
2019$53.57353.48%
2018$11.811025%
2017$1.05-700%
2016-$0.18-100.87%
2015$20.231859.32%
2014$1.035.36%
2013$0.988.0704505322479E+18%
2012$0.0000000000-100%
2011$0.86-194.23%
2010-$0.91548.38%
2009-$0.14-98.7%
2008-$10.82-136.52%
2007$29.61-787.8%
2006-$4.31-14.58%
2005-$5.04-21.31%
2004-$6.41-55.15%
2003-$14.2881.33%
2002-$7.882.74%
2001-$7.67-45.93%
2000-$14.18-14.56%
1999-$16.59-45.52%
1998-$30.45-3.97%
1997-$31.71132.31%
1996-$13.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$24.77 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.63-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.13 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.19 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.26 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.50 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.95 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.96 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.65 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA